Boston Heart Diagnostics

About:

Boston Heart Lab is a heart health management company that provides cardiovascular disease (CVD) management.

Website: http://www.bostonheartdiagnostics.com

Twitter/X: BostonHeartDX

Top Investors: Bain Capital Ventures, Keiretsu Forum, SustainVC, Cherrystone Angel Group

Description:

Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management. Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.

Total Funding Amount:

$10.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Framingham, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)bostonheartdiagnostics.com

Founders:

Bela Asztalos, Ernst Schaefer

Number of Employees:

51-100

Last Funding Date:

2011-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai